CPPD Linked to Longer Stays and Higher Stroke Care Costs

Stroke patients who also have calcium pyrophosphate deposition disease, a crystal-related joint condition, appear to face longer hospital stays and higher total charges than stroke patients without the disease, according to a retrospective analysis of a large United States hospital database. The study, published in BMC Rheumatology, drew on the National Inpatient Sample from 2015 to 2019 and identified adult hospitalizations for stroke, with calcium pyrophosphate deposition disease diagnoses determined using ICD codes.

The analysis covered 1,834,410 weighted stroke admissions, of which 1,120, or 0.06 percent, carried a co-diagnosis of calcium pyrophosphate deposition disease. Patients with the condition were older and had a higher comorbidity burden than those without it. Lower in-hospital mortality was observed in this group, although that difference was attenuated when the researchers performed a propensity score matched analysis designed to address baseline differences in cardiovascular risk profile.

Beyond survival, the study found that patients with calcium pyrophosphate deposition disease had longer hospital stays and higher total charges, indicating greater healthcare resource utilization during their admissions. The authors concluded that stroke patients with the disease represent an older, more comorbid population with greater healthcare utilization, and they noted that the mortality finding warrants further investigation in prospective studies with clinical data on disease activity and treatment.

The research team, which included Hayley Kunde, Anna Yayloyan, Konstantinos Parperis and Costas Christophi, framed the work around a biological question: calcium pyrophosphate deposition disease may contribute to vascular risk through systemic inflammation and calcification, yet its impact on stroke outcomes had remained underexplored. Their aim was to evaluate the clinical characteristics, in-hospital outcomes, and healthcare resource utilization of stroke patients with and without the condition.

Methodologically, the study used multivariable regression models adjusted for age, sex, year, comorbidities and, where relevant, length of stay. Because the two patient groups differed substantially at baseline, the investigators also performed the propensity score matched analysis to account for differences in cardiovascular risk profile before comparing outcomes. This design addresses, but cannot fully eliminate, the limitations inherent in retrospective administrative data, in which coding practices and missing clinical detail can shape the results.

The database findings align with that demographic pattern, since the affected stroke admissions involved older patients with more coexisting illnesses. Whether the crystals themselves influence vascular disease, or whether the observed differences simply reflect age and comorbidity, remains a question the authors say requires prospective research with direct clinical measurements of disease activity and treatment.

The study was published as open access research in BMC Rheumatology on 10 September 2026, with the article shared early to provide faster access to peer-reviewed, accepted research carrying a permanent DOI. As a retrospective database analysis, it describes associations observed across hospitalizations rather than testing an intervention, and the authors explicitly flag the mortality result as a signal that needs confirmation rather than a settled conclusion.

For clinicians and health services researchers, the practical takeaway is resource-related: stroke admissions complicated by calcium pyrophosphate deposition disease consumed more hospital resources, with longer stays and higher total charges, in a population that was older and sicker at baseline. The authors suggest that future prospective studies incorporating clinical data on disease activity and treatment will be needed to clarify the mortality signal and to determine whether managing the crystal disease could influence outcomes after stroke.

Subject of Research: In-hospital outcomes and healthcare utilization among stroke patients with calcium pyrophosphate deposition disease in a retrospective National Inpatient Sample analysis

Article Title: In-hospital outcomes of stroke patients with calcium pyrophosphate deposition disease: a retrospective analysis of the national inpatient sample

Article References: Kunde, H., Yayloyan, A., Parperis, K., & Christophi, C. (2026). In-hospital outcomes of stroke patients with calcium pyrophosphate deposition disease: a retrospective analysis of the national inpatient sample. BMC Rheumatology. https://doi.org/10.1186/s41927-026-00688-y

Image Credits: AI Generated

DOI: 10.1186/s41927-026-00688-y

Keywords: calcium pyrophosphate deposition disease, CPPD, stroke, National Inpatient Sample, in-hospital mortality, hospital length of stay, healthcare utilization, propensity score matching, retrospective analysis, BMC Rheumatology, comorbidity, total hospital charges